CLINICAL TRIAL: PEDIATRIC PHARMACOKINETIC AND TOLERABILITY STUDY OF LITHIUM FOR

临床试验：锂的儿科药代动力学和耐受性研究

• 批准号: 7719277
• 负责人: VIVIAN KAFANTARIS
• 金额: $ 17.59万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-22 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7719277
• 关键词: Childhood; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Disease; Drug Kinetics; Effectiveness; Funding; Grant; Institution; Lithium; Multicenter Trials; Patients; Phase; Research; Research Personnel; Resources; Source; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a multiphase, multicenter, trial that will comprehensively examine lithium in the treatment of pediatric patients with bipolar I disorder. This study includes four treatment phases, including a pharmacokinetic phase, a long-term effectiveness phase, a discontinuation phase and a restabilization phase.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 这是一项多阶段、多中心试验，将全面检查锂在治疗 I 型双相情感障碍儿科患者中的作用。 该研究包括四个治疗阶段，包括药代动力学阶段、长期有效性阶段、停药阶段和重新稳定阶段。